Current Perspectives in Bladder Cancer Management
Current Perspectives in Bladder Cancer Management
A joint consensus statement published by the Renal Association and BAUS, followed by a review article, emphasised the importance of a basic nephrological screen in all patients with NVH. Almost one-half of patients referred to urological haematuria clinics have NVH; however in this setting, patients with NVH are twice as likely to have nephrological disease (10%) than bladder cancer (5%). The overall incidence of urological malignancy in screen-detected a-NVH is < 1%.
All patients with s-NVH and persistent a-NVH should have their baseline blood pressure (BP), estimated glomerular filtration rate (eGFR), and albumin:creatinine ratio (ACR) measured (Table 1). Further nephrological assessment should be considered in those aged < 40 years with persistent a-NVH if any one of eGFR < 60 ml/min/1.73 m, ACR > 30 or BP > 140/90 mmHg are present.
What Initial Investigations Should Be Performed in Primary Care?
A joint consensus statement published by the Renal Association and BAUS, followed by a review article, emphasised the importance of a basic nephrological screen in all patients with NVH. Almost one-half of patients referred to urological haematuria clinics have NVH; however in this setting, patients with NVH are twice as likely to have nephrological disease (10%) than bladder cancer (5%). The overall incidence of urological malignancy in screen-detected a-NVH is < 1%.
All patients with s-NVH and persistent a-NVH should have their baseline blood pressure (BP), estimated glomerular filtration rate (eGFR), and albumin:creatinine ratio (ACR) measured (Table 1). Further nephrological assessment should be considered in those aged < 40 years with persistent a-NVH if any one of eGFR < 60 ml/min/1.73 m, ACR > 30 or BP > 140/90 mmHg are present.
Source...